Dr Leila Kheirandish, MD, MSC | |
404 N Keene St, Columbia, MO 65201-6626 | |
(573) 882-6921 | |
(573) 884-3991 |
Full Name | Dr Leila Kheirandish |
---|---|
Gender | Female |
Speciality | Pediatrics - Sleep Medicine |
Location | 404 N Keene St, Columbia, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326698929 | NPI | - | NPPES |
200076954 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 2019035455 (Missouri) | Secondary |
2080S0012X | Pediatrics - Sleep Medicine | 2019035455 (Missouri) | Primary |
Entity Name | The Curators Of The University Of Missouri |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235126921 PECOS PAC ID: 4486759560 Enrollment ID: O20070418000290 |
News Archive
Apexigen, Inc., an emerging biopharmaceutical company focused on the discovery and development of monoclonal antibody therapeutics, announced today that its partner, 3SBio [SSRX] of Shenyang, China, filed an Investigational New Drug (IND) application for APX001, also known as SSS07, with the State Food and Drug Administration (SFDA) in China.
Of all the groups that try to quit smoking, it seems hardest for those who suffer from anxiety and depression. The health effects are jarring: People with mental illness or substance use disorders die about five years earlier than those without these disorders and many of those deaths are caused by smoking cigarettes, according to the Centers for Disease Control and Prevention.
The population of the UK is ageing. Sixteen per cent of the UK population is 65 or older, and for the first time, there are more people over the age of 65 than there are under the age of 18. This raises a lot of questions on issues such as pension provision, health care and wellbeing. Ensuring that elderly people have access to medical and social support; the use of new technologies to make it easier for them to live independent lives; and helping the elderly to stay active within society.
Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the Company's supplemental new drug application (sNDA) for VELCADE. The sNDA contains long-term overall survival (OS) data from the landmark VISTA trial examining the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Leila Kheirandish, MD, MSC Po Box 843966, Kansas City, MO 64184-3966 Ph: (573) 884-3300 | Dr Leila Kheirandish, MD, MSC 404 N Keene St, Columbia, MO 65201-6626 Ph: (573) 882-6921 |
News Archive
Apexigen, Inc., an emerging biopharmaceutical company focused on the discovery and development of monoclonal antibody therapeutics, announced today that its partner, 3SBio [SSRX] of Shenyang, China, filed an Investigational New Drug (IND) application for APX001, also known as SSS07, with the State Food and Drug Administration (SFDA) in China.
Of all the groups that try to quit smoking, it seems hardest for those who suffer from anxiety and depression. The health effects are jarring: People with mental illness or substance use disorders die about five years earlier than those without these disorders and many of those deaths are caused by smoking cigarettes, according to the Centers for Disease Control and Prevention.
The population of the UK is ageing. Sixteen per cent of the UK population is 65 or older, and for the first time, there are more people over the age of 65 than there are under the age of 18. This raises a lot of questions on issues such as pension provision, health care and wellbeing. Ensuring that elderly people have access to medical and social support; the use of new technologies to make it easier for them to live independent lives; and helping the elderly to stay active within society.
Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the Company's supplemental new drug application (sNDA) for VELCADE. The sNDA contains long-term overall survival (OS) data from the landmark VISTA trial examining the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).
› Verified 5 days ago
Bailey M Clancy, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Hospital Drive Pediatrics Dc058.00, Columbia, MO 65212 Phone: 573-882-4438 Fax: 573-884-9992 | |
Daniela Cristina Bichianu, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 404 N Keene St, Columbia, MO 65201 Phone: 573-882-2272 Fax: 573-884-1795 | |
Dr. Danielle Renee Keebaugh, MD Pediatrics Medicare: Medicare Enrolled Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-6544 Fax: 573-882-2256 | |
Nathan K Beckett, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 404 N Keene St, Columbia, MO 65201 Phone: 573-882-4438 Fax: 573-884-9992 | |
Abdul-azeez Abdullahi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-4438 Fax: 573-884-9992 | |
Melissa A Lawson, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 404 N Keene St Ste 101, Columbia, MO 65201 Phone: 573-882-6921 Fax: 573-884-5226 | |
Dr. Laura E. Henderson Kelley, M.D, MPH Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 101 S Fairview Rd, Columbia, MO 65203 Phone: 573-882-4464 |